http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4288591-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f88f84fc279fe5d0b9b5ec3c88c2e2b2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-44 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-44 |
filingDate | 1980-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1981-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f52a9bd19f7f7804bd0685a525b877f4 |
publicationDate | 1981-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4288591-A |
titleOfInvention | 4-Substituted 2-iminoimidazolidine compounds |
abstract | This invention provides a novel class of 2-iminoimidazolidines which include 4-substituted derivatives such as 4-(2-chloroethyl)-1-methyl-2-methylimino-3-phenyl imidazolidine fumarate: <IMAGE> This illustrated 4-substituted 2-iminoimidazolidine compound exhibits cardiovascular hypotensive, hypoglycemic (glucose tolerance, and sugar cataract) and anti-inflammatory (pleural effusion) pharmacological activities in test animals. |
priorityDate | 1979-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 416.